57G-34507-10300
4 vaccinations
4 coded responses
15 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 283 / NC
- Registered
- 2021-01-28
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-08
Dose 1 — Pfizer-BioNTech
-
2021-01-28
Registered in v-safe
- 2021-01-28
-
2021-01-29
Dose 2 — Pfizer-BioNTech
- 2021-02-11
- 2021-02-12
- 2021-02-26
- 2021-03-08
- 2021-03-12
-
2021-04-30
Survey response — 3 months, dose 2MedDRA: Asthma, Dysphonia, Headache, Peripheral swelling, Pre-existing disease, Self-medication — Feeling: GoodFree text: Leg swelling, headache, hoarseness, and asthma exacerbation for 5 days and resolved on own with use of Albuterol and steroid inhalers, and Tylenol as neededMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-30
-
2021-09-30
Dose 3 — Pfizer-BioNTech
-
2022-01-29
Survey response — 12 months, dose 2MedDRA: Diarrhoea, Exposure to SARS-CoV-2, Rhinorrhoea — Feeling: FairFree text: 2nd day of loose stools and runny nose. But 4 days ago exposed to a coworker who was Covid positive- but I had on my N95 mask.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-31
Survey response — 6 months, dose 3MedDRA: Adverse reaction, Dyspnoea — Feeling: FairFree text: Severe allergy symptoms with more sob leading to use of Alb inh more. Symptoms a week now but improving significantly today.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-01
Dose 4 — Pfizer-BioNTech
-
2022-04-22
Survey response — day 21, dose 4MedDRA: Sinus congestion, Sneezing — Feeling: FairFree text: Severe sinus congestion with excessive sneezing on allergy medicationsMedDRA releases: 2024-11 · check-in free text available
- 2022-04-29
- 2022-05-06
- 2022-05-16
- 2023-04-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-08 | Pfizer-BioNTech | |
| 2 | 2021-01-29 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
| 4 | 2022-04-01 | Pfizer-BioNTech | No |
Free text
Release 8 — 3 months, dose 2
Symptoms: Leg swelling, headache, hoarseness, and asthma exacerbation for 5 days and resolved on own with use of Albuterol and steroid inhalers, and Tylenol as needed
Release 11 — 12 months, dose 2
Symptoms: 2nd day of loose stools and runny nose. But 4 days ago exposed to a coworker who was Covid positive- but I had on my N95 mask.
Release 11 — 6 months, dose 3
Symptoms: Severe allergy symptoms with more sob leading to use of Alb inh more. Symptoms a week now but improving significantly today.
Release 11 — day 21, dose 4
Symptoms: Severe sinus congestion with excessive sneezing on allergy medications
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Adverse reaction | · | · | ✓ |
| SD | Asthma | ✓ | ✓ | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dysphonia | ✓ | ✓ | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Peripheral swelling | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Self-medication | ✓ | ✓ | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release